Introduction
The Epidermal Growth Factor Receptor (EGFR) plays a critical role in cellular growth, differentiation, and survival. Mutations or overexpression of EGFR have been strongly linked to the development and progression of various cancers, including non-small cell lung cancer (NSCLC), colorectal cancer, and head and neck squamous cell carcinoma (HNSCC). The EGFR inhibitors market has...
The Epidermal Growth Factor Receptor (EGFR) market has been gaining significant traction in the pharmaceutical and biotechnology sectors due to its critical role in oncology. The Epidermal Growth Factor Receptor Market encompasses a range of drugs designed to inhibit EGFR, which is overexpressed in various cancers, including lung, colorectal, and head and neck cancers. These inhibitors are...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian